NOD2 agonist 2
NOD2 agonist 2 (compound 23) enhanced the antigen presentation of mouse bone marrow-derived dendritic cells (BMDCs), highlighting its potential as a vaccine adjuvant.
Product Specifications
UNSPSC
12352211
Target
NOD-like Receptor (NLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nod2-agonist-2.html
Smiles
O=C(N[C@H](CCC(OCC)=O)C(OCC)=O)[C@H](C(C)C)NC(CNC(/C=C/C1=CC(OC)=C(C=C1)OC(CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)=O)=O
Molecular Formula
C46H65N3O10
Molecular Weight
820.02
References & Citations
[1]Janež Š, et al. Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists. J Med Chem. 2024 Oct 10;67 (19) :17585-17607.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400787-500 1x 500 µL
TGFalpha (P/T1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 